• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后支原体肺炎继发感染儿童的免疫反应:聚焦嗜酸性粒细胞和免疫球蛋白E

Immune responses in children with secondary infection of mycoplasma pneumoniae after COVID-19: focus on eosinophils and IgE.

作者信息

Wang Pingping, Yao Jin, Li Yaqiong, Zhang Zhanjun, Zhang Ruiling, Lu Shouting, Sun Meixia, Huang Xiaorong

机构信息

Department of Medical Laboratory, Luoyang Maternal and Child Health Hospital, 206 Tongqu Road, Luolong District, Luoyang City, Henan Province, China.

Department of Infection and Public Health Management, The Second Affiliated Hospital of Henan University of Science and Technology, No. 80 Jinguyuan Road, Xigong District, Luoyang City, Henan Province, China.

出版信息

BMC Infect Dis. 2025 Jan 28;25(1):134. doi: 10.1186/s12879-025-10534-0.

DOI:10.1186/s12879-025-10534-0
PMID:39875814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11773693/
Abstract

BACKGROUND

The COVID-19 (SARS-CoV-2) epidemic has posed a major challenge to global public health, especially in children. Some children may experience secondary infection with Mycoplasma pneumoniae after SARS-CoV-2 infection, which has attracted widespread attention. Studies have shown that eosinophils play an important role in respiratory tract infections and are involved in regulating immune responses and inflammatory processes. However, there is a lack of systematic research on the specific manifestations and mechanisms of eosinophils in secondary infection with Mycoplasma pneumoniae after SARS-CoV-2 infection.

OBJECTIVE

This study aims to explore the characteristics of immune response in children with SARS-CoV-2 infection and Mycoplasma pneumoniae infection, focusing on the changes in immune indicators such as eosinophils (EOS), immunoglobulin E (IgE), interleukin-6 (IL-6), C-reactive protein (CRP), and procalcitonin (PCT).

METHODS

This study is a retrospective observational study, and a total of pediatric patients who were treated in our hospital from January 2023 to December 2023 were included. The study group included children who were diagnosed with SARS-CoV-2 infection and further infected with Mycoplasma pneumoniae, and the control group included children who were only infected with SARS-CoV-2 and had no other pathogens. The clinical data of the two groups of patients, including absolute eosinophil value, IgE quantification, IL-6, CRP and PCT levels, were collected and analyzed, and statistical comparisons were performed.

RESULTS

A total of 134 children were included, including 79 in the study group and 55 in the control group. The absolute eosinophil value [0.17 (0.09, 0.31) vs. 0.09 (0.06, 0.23), P < 0.01] and IgE level [59.28 (37.54, 256.88) vs. 22.00 (11.00, 113.10) P < 0.01] of the children in the study group were significantly higher than those in the control group, while IL-6 [16.81(4.72,31.86) vs. 9.5(3,57.3), P = 0.602], CRP [2.82(1.10,6.13) vs. 1.94(0.50,8.94), P = 0.528] and PCT[0.12(0.08,0.20) vs. 0.12(0.10,0.24), P = 0.329] were no significant difference between the two groups. Binary logistic regression analysis showed that the absolute value of eosinophils and IgE were independent risk factors for secondary infection of Mycoplasma pneumoniae after SARS-CoV-2 infection.

CONCLUSION

This study shows that after SARS-CoV-2 infection, the increase in eosinophils and the increase in related immune indicators IgE may be closely related to secondary infection with Mycoplasma pneumoniae. This study provides an important basis for understanding the immune response of children after SARS-CoV-2 infection and its related clinical management, suggesting that clinicians should closely monitor the eosinophil count and IgE level of children after SARS-CoV-2 infection, especially for children at risk of secondary infection, so as to take timely intervention measures to prevent secondary infection with Mycoplasma pneumoniae and improve the prognosis of children.

摘要

背景

新型冠状病毒肺炎(SARS-CoV-2)疫情给全球公共卫生带来了重大挑战,尤其是对儿童。一些儿童在感染SARS-CoV-2后可能继发肺炎支原体感染,这引起了广泛关注。研究表明,嗜酸性粒细胞在呼吸道感染中起重要作用,并参与调节免疫反应和炎症过程。然而,对于SARS-CoV-2感染后肺炎支原体继发感染中嗜酸性粒细胞的具体表现及机制缺乏系统研究。

目的

本研究旨在探讨感染SARS-CoV-2和肺炎支原体的儿童的免疫反应特征,重点关注嗜酸性粒细胞(EOS)、免疫球蛋白E(IgE)、白细胞介素-6(IL-6)、C反应蛋白(CRP)和降钙素原(PCT)等免疫指标的变化。

方法

本研究为回顾性观察性研究,纳入2023年1月至2023年12月在我院治疗的儿科患者。研究组包括诊断为SARS-CoV-2感染并继发肺炎支原体感染的儿童,对照组包括仅感染SARS-CoV-2且无其他病原体的儿童。收集并分析两组患者的临床资料,包括嗜酸性粒细胞绝对值、IgE定量、IL-6、CRP和PCT水平,并进行统计学比较。

结果

共纳入134例儿童,研究组79例,对照组55例。研究组儿童的嗜酸性粒细胞绝对值[0.17(0.09,0.31)对0.09(0.06,0.23),P<0.01]和IgE水平[59.28(37.54,256.88)对22.00(11.00,113.10),P<0.01]显著高于对照组,而IL-6[16.81(4.72,31.86)对9.5(3,57.3),P = 0.602]、CRP[2.82(1.10,6.13)对1.94(0.50,8.94),P = 0.528]和PCT[0.12(0.08,0.20)对0.12(0.10,0.24),P = 0.329]两组间无显著差异。二元logistic回归分析显示,嗜酸性粒细胞绝对值和IgE是SARS-CoV-2感染后肺炎支原体继发感染的独立危险因素。

结论

本研究表明,SARS-CoV-2感染后,嗜酸性粒细胞增多及相关免疫指标IgE升高可能与肺炎支原体继发感染密切相关。本研究为了解SARS-CoV-2感染后儿童的免疫反应及其相关临床管理提供了重要依据,提示临床医生应密切监测SARS-CoV-2感染后儿童的嗜酸性粒细胞计数和IgE水平,尤其是对于有继发感染风险的儿童,以便及时采取干预措施,预防肺炎支原体继发感染,改善儿童预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6171/11773693/6aa63c4567e5/12879_2025_10534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6171/11773693/6aa63c4567e5/12879_2025_10534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6171/11773693/6aa63c4567e5/12879_2025_10534_Fig1_HTML.jpg

相似文献

1
Immune responses in children with secondary infection of mycoplasma pneumoniae after COVID-19: focus on eosinophils and IgE.新冠病毒感染后支原体肺炎继发感染儿童的免疫反应:聚焦嗜酸性粒细胞和免疫球蛋白E
BMC Infect Dis. 2025 Jan 28;25(1):134. doi: 10.1186/s12879-025-10534-0.
2
Analysis of clinical characteristics and laboratory examination data of 112 cases of Mycoplasma pneumoniae pneumonia in children.112例儿童支原体肺炎临床特征及实验室检查资料分析
Medicine (Baltimore). 2024 Nov 22;103(47):e40628. doi: 10.1097/MD.0000000000040628.
3
Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections.应用随机森林和生物标志物鉴别 COVID-19 和肺炎支原体感染。
Sci Rep. 2024 Sep 30;14(1):22673. doi: 10.1038/s41598-024-74057-5.
4
Seroprevalence and Total IgE Levels in Patients with Juvenile Idiopathic Arthritis.青少年特发性关节炎患者的血清患病率和总 IgE 水平。
J Immunol Res. 2021 Oct 6;2021:6596596. doi: 10.1155/2021/6596596. eCollection 2021.
5
Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.《中国某单一中心 78 例 COVID-19 肺炎患者合并常见呼吸道病原体感染及实验室生物化学检查结果的回顾性横断面研究》
Med Sci Monit. 2021 Jan 3;27:e929783. doi: 10.12659/MSM.929783.
6
High ratio of C-reactive protein/procalcitonin predicts infection among adults hospitalized with community acquired pneumonia.高 C 反应蛋白/降钙素原比值预测成人社区获得性肺炎住院患者的感染。
Scand J Clin Lab Invest. 2021 Feb;81(1):65-71. doi: 10.1080/00365513.2020.1858491. Epub 2020 Dec 21.
7
Synergistic impact of macrolide resistance and H3N2 infection on outbreak in children.大环内酯类耐药性与H3N2感染对儿童疫情的协同影响。
Microbiol Spectr. 2025 Apr;13(4):e0184424. doi: 10.1128/spectrum.01844-24. Epub 2025 Feb 25.
8
Mycoplasma pneumoniae infection in a pediatric population: analysis of soluble immune markers as risk factors for asthma.儿科人群中的肺炎支原体感染:可溶性免疫标志物作为哮喘危险因素的分析
Hum Immunol. 2008 Dec;69(12):851-5. doi: 10.1016/j.humimm.2008.09.003. Epub 2008 Oct 7.
9
[Comparative analysis of clinical characteristics and prognosis between bacterial necrotizing pneumonia and necrotizing pneumonia in children].儿童细菌性坏死性肺炎与坏死性肺炎的临床特征及预后比较分析
Zhonghua Er Ke Za Zhi. 2019 Aug 2;57(8):625-630. doi: 10.3760/cma.j.issn.0578-1310.2019.08.011.
10
A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection.高 C 反应蛋白/降钙素原比值可预测肺炎支原体感染。
Clin Chem Lab Med. 2019 Sep 25;57(10):1638-1646. doi: 10.1515/cclm-2019-0194.

本文引用的文献

1
Reemergence of Mycoplasma pneumoniae disease: Pathogenesis and new approaches.肺炎支原体病的再发:发病机制与新方法。
Microb Pathog. 2024 Nov;196:106944. doi: 10.1016/j.micpath.2024.106944. Epub 2024 Sep 14.
2
A comparative study of general and severe mycoplasma pneumoniae pneumonia in children.儿童普通型与重症肺炎支原体肺炎的对比研究。
BMC Infect Dis. 2024 Apr 26;24(1):449. doi: 10.1186/s12879-024-09340-x.
3
Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.
儿童社区获得性肺炎支原体的临床特征和血清炎症标志物。
Clin Respir J. 2023 Jul;17(7):607-617. doi: 10.1111/crj.13620. Epub 2023 May 4.
4
Recent advances in understanding the role of eosinophils.嗜酸性粒细胞作用认识的最新进展。
Fac Rev. 2022 Sep 27;11:26. doi: 10.12703/r/11-26. eCollection 2022.
5
Epidemiological and hematological investigation of dengue virus infection.登革热病毒感染的流行病学和血液学研究。
Microbiol Immunol. 2022 Sep;66(9):426-432. doi: 10.1111/1348-0421.13018. Epub 2022 Jul 18.
6
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions.嗜酸性粒细胞的新作用:对嗜酸性粒细胞相关炎症性疾病靶向治疗的启示。
Curr Res Immunol. 2022 Mar 21;3:42-53. doi: 10.1016/j.crimmu.2022.03.002. eCollection 2022.
7
TGF-β production by eosinophils drives the expansion of peripherally induced neuropilin RORγt regulatory T-cells during bacterial and allergen challenge.嗜酸性粒细胞产生 TGF-β 驱动外周诱导的神经纤毛蛋白 RORγt 调节性 T 细胞在细菌和过敏原挑战期间的扩增。
Mucosal Immunol. 2022 Mar;15(3):504-514. doi: 10.1038/s41385-022-00484-0. Epub 2022 Feb 15.
8
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.新冠病毒感染发病率、严重程度和死亡率的风险和保护因素。
Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19.
9
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.新冠肺炎患者疾病过程中恢复期和死亡患者嗜酸性粒细胞计数的变化。
Viruses. 2021 Aug 24;13(9):1675. doi: 10.3390/v13091675.
10
COVID-19 in Children: Where do we Stand?儿童 COVID-19:我们处于什么位置?
Arch Med Res. 2022 Jan;53(1):1-8. doi: 10.1016/j.arcmed.2021.07.002. Epub 2021 Jul 6.